The Melanoma New Zealand is a registered charitable trust devoted to issues relating to melanoma. Our mission is to prevent avoidable deaths from melanoma and alleviate anxiety among those affected by it.
Melanoma New Zealand
National Melanoma Standards
The national melanoma standards where developed by experts in the field and funded by the Ministry of Health. The aim of the standards was to improve melanoma care in NZ.
Australian and New Zealand Melanoma Trials Group
The Australia and New Zealand Melanoma Trials Group (ANZMTG) coordinates and conducts quality research for melanoma control with researchers and health care professionals, support networks and consumers.
The Health Promotion Agency (HPA) is a New Zealand crown agency that promotes good health and encourages healthy lifestyles. The long-term focus of the HPA is on reducing the social, financial and health sector costs of smoking, skin cancer, problem gambling, and obesity. The prevention of skin cancer and the promotion of sun safety in New Zealand is lead by the HPA and the Cancer Society of New Zealand, under the SunSmart brand.
Cancer Trials NZ
The overarching objective of Cancer Trials New Zealand (CTNZ) is to contribute to the ‘New Zealand Cancer Control Strategy’ commitment to improve cancer control through research.
Established in 2003, Cancer Trials New Zealand was developed to assist clinical researchers and the existing Cancer research units by creating an adaptive infrastructure to facilitate more rapid development of new ideas from investigators across all disciplines.
The primary focus of the group is on encouraging and supporting investigator initiated phase I and II oncology trials. As the capacity of the trial centre increases, it will encourage more early phase / translational projects in collaboration with the New Zealand and international biotechnology and pharmaceutical industry. The group is also exploring linkages with initiatives such as rare tumour registries, pathology repositories, and national clinical databases.
Establishment of the basic structure of Cancer Trials New Zealand was made possible by a three-year foundation seeding grant from the Auckland Cancer Society.
It’s their mission to improve health and other outcomes for New Zealand by providing a national resource to facilitate clinical trials research in cancer.
Melanoma Institute of Australia
Melanoma Institute Australia (MIA) pioneers advances in melanoma research and treatment that are making a difference to the lives of patients today.
They are a non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs.
MIA is a national affiliated network of melanoma researchers and clinicians based in Sydney at the Poche Centre – the world’s largest melanoma research and treatment facility. It’s from here that their specialists pioneer new research, conduct clinical trials, develop new treatments and promote awareness of melanoma and where their clinics treat 1,500 melanoma patients each year.